Alpha Teknova (TKNO) Accounts Payables (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Accounts Payables came in at $1.6 million in Q1 2026, up 4.05% year-on-year from $1.6 million in Q1 2025, and up 17.42% on a QoQ basis from $1.4 million in Q4 2025.
Alpha Teknova (TKNO) Accounts Payables (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Accounts Payables data on file, last reported at $1.6 million in Q1 2026.
- On a quarterly basis, Accounts Payables rose 4.05% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $1.6 million, a 4.05% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 67.03% from the prior year.
- Accounts Payables for Q1 2026 stood at $1.6 million, up from $1.4 million in the prior quarter.
- Over the last five years, Accounts Payables for TKNO reached as high as $3.5 million in Q3 2022 and fell as low as $825000.0 in Q4 2024.
- Historically, Accounts Payables has averaged $1.6 million across 5 years, with a median of $1.4 million in 2023.
- Across the five-year window, Accounts Payables slumped 59.2% in 2023 and soared 67.03% in 2025, its largest moves.
- Year by year, Accounts Payables stood at $2.4 million in 2022, then tumbled by 39.04% to $1.5 million in 2023, then tumbled by 44.74% to $825000.0 in 2024, then surged by 67.03% to $1.4 million in 2025, then gained by 17.42% to $1.6 million in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $1.6 million in Q1 2026, $1.4 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | 1.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.62 Mn |
| Dec 31, 2025 | 1.38 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.56 Mn |
| Dec 31, 2024 | 825,000.00 |
| Sep 30, 2024 | 975,000.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.49 Mn |
| Sep 30, 2023 | 1.42 Mn |
| Jun 30, 2023 | 1.08 Mn |
| Mar 31, 2023 | 1.89 Mn |
| Dec 31, 2022 | 2.45 Mn |
| Sep 30, 2022 | 3.49 Mn |
| Jun 30, 2022 | 1.42 Mn |
| Mar 31, 2022 | 3.03 Mn |
| Dec 31, 2021 | 2.25 Mn |
| Sep 30, 2021 | 3.32 Mn |
| Jun 30, 2021 | 2.64 Mn |